Quantcast
Last updated on April 16, 2014 at 16:55 EDT

Latest Vito Quaranta Stories

2012-08-13 15:07:00

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy — and may offer a way to further refine personalized cancer treatments. The approach, developed by investigators at Vanderbilt-Ingram Cancer Center, shows that erlotinib — a targeted therapy that acts on a growth factor receptor mutated in some lung, brain and other cancers — doesn't simply kill tumor cells as was previously assumed. The drug also causes some tumor...